Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure
Amgen Inc (NASDAQ: AMGN) Delayed: 346.69 +1.97 (0.57%)
Previous Close $344.72    52 Week High $176.85 
Open $348.31    52 Week Low $133.64 
Day High $349.40    P/E 52.21 
Day Low $345.49    EPS $6.64 
Volume 538,510       

CYTOKINETICS (NASDAQ: CYTK) Delayed: 78.74 -0.43 (0.54%)
Previous Close $79.17    52 Week High $13.18 
Open $78.99    52 Week Low $6.00 
Day High $80.40    P/E N/A 
Day Low $78.27    EPS $-1.24 
Volume 552,995